These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24828936)

  • 21. Myopathy associated with statin therapy.
    Hilton-Jones D
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract]   [Full Text] [Related]  

  • 22. Statin myopathy: a review of recent progress.
    Mammen AL; Amato AA
    Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.
    Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M
    Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune-mediated necrotising myopathy linked to statin use.
    Kipfer S; Frigerio S; Hench J; Aussy A; Boyer O
    Lancet; 2015 Oct; 386(10005):e26. PubMed ID: 26074381
    [No Abstract]   [Full Text] [Related]  

  • 25. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy.
    Floyd JS; Brody JA; Tiniakou E; Psaty BM; Mammen A
    Muscle Nerve; 2016 Jun; 54(1):142-4. PubMed ID: 27038110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of statin safety by muscle experts.
    Thompson PD; Clarkson PM; Rosenson RS;
    Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin-induced necrotizing autoimmune myopathy: importance of early recognition.
    Hussenbux A; Hofer M; Steuer A
    Br J Hosp Med (Lond); 2017 Jun; 78(6):352-353. PubMed ID: 28614015
    [No Abstract]   [Full Text] [Related]  

  • 30. Myopathy: five new things.
    Oskarsson B
    Neurology; 2011 Feb; 76(7 Suppl 2):S14-9. PubMed ID: 21321346
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy.
    Stringer HA; Sohi GK; Maguire JA; Côté HC
    J Neurol Sci; 2013 Feb; 325(1-2):142-7. PubMed ID: 23312852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
    Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
    Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
    [No Abstract]   [Full Text] [Related]  

  • 33. Statin-related myopathy.
    Dobkin BH
    Arch Intern Med; 2006 Jun; 166(11):1232; author reply 1233. PubMed ID: 16772253
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations from a statin myopathy clinic.
    Phillips PS; Haas RH
    Arch Intern Med; 2006 Jun; 166(11):1232-3; author reply 1233. PubMed ID: 16772252
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies.
    Close RM; Close LM; Galdun P; Gerstberger S; Rydberg M; Christopher-Stine L
    Rheumatology (Oxford); 2021 Feb; 60(2):692-698. PubMed ID: 32789452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
    Waters MJ; Limaye V
    Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy.
    Scard C; Bara-Passot C; Chassain K; Maillard H
    Acta Derm Venereol; 2021 Mar; 101(3):adv00415. PubMed ID: 32985673
    [No Abstract]   [Full Text] [Related]  

  • 38. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuromuscular symptoms and elevated creatine kinase after statin withdrawal.
    Echaniz-Laguna A; Mohr M; Tranchant C
    N Engl J Med; 2010 Feb; 362(6):564-5. PubMed ID: 20147729
    [No Abstract]   [Full Text] [Related]  

  • 40. When Statins Cause an Autoimmune Response: A Report of a Severe Case of Rhabdomyolysis.
    Hasan S; Abushahin A; Prayson R; Kilani A
    Am J Med; 2020 Jan; 133(1):50-51. PubMed ID: 31247184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.